Editorial commentary: Is the debate about treatment of Candida parapsilosis complex infections with echinocandins much ado about nothing?

Clinical Infectious Diseases

Volumn 58, Issue 10, 2014, Pages 1422-1423

  Reboli, Annette C ^a  

^a Department of Anesthesiology   (United States)

Author keywords

Candida parapsilosis; Candidemia; Echinocandins; Observational study; Propensity scoring.

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; MICAFUNGIN;

BLOOD CULTURE; BLOODSTREAM INFECTION; CANDIDA PARAPSILOSIS; CANDIDEMIA; CANDIDIASIS; CATHETER INFECTION; CATHETER REMOVAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ERADICATION THERAPY; FUNGAL VIRULENCE; FUNGICIDAL ACTIVITY; HUMAN; INTRAVASCULAR CATHETER; INVASIVE CANDIDIASIS; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; NOTE; PARENTERAL NUTRITION; PRIORITY JOURNAL; FEMALE; MALE;

ANTIFUNGAL AGENTS; CANDIDEMIA; ECHINOCANDINS; FEMALE; HUMANS; MALE;

EID: 84899892546     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu160     Document Type: Note

References (7)

1. Salas V, Pastor FJ, Capilla J, et al. Evaluation ofthe correlation of caspofungin MICs and treatmentoutcome in murine infections by wildtype strains of Candida parapsilosis. Diag MicrobiolInfect Dis 2013; 77:41-5.
2. Mora-Duarte J, Betts R, Rotstein C, et al. Comparisonof caspofungin and amphotericin Bfor invasive candidiasis. N Engl J Med 2002;347:2020-9.
3. Pappas PG, Rotstein CM, Betts RF, et al. Micafunginversus caspofungin for treatment ofcandidemia and other forms of invasive candidiasis.Clin Infect Dis 2007; 45:883-93.
4. Reboli AC, Rotstein C, Pappas PG, et al. Anidulafunginversus fluconazole for invasivecandidiasis. N Engl J Med 2007; 356:2472-82.
5. Andes DR, Safdar N, Baddley JW, et al. Impactof treatment strategy on outcomes in patientswith candidemia and other forms of invasivecandidiasis: a patient-level quantitative reviewof randomized trials. Clin Infect Dis 2012;54:1110-22.
6. Fernández-Ruiz M, Aguado JM, Almirante B,et al. Initial use of echinocandins does not negativelyinfluence outcome in Candida parapsilosisbloodstream infection: a propensity scoreanalysis. Clin Infect Dis 2014; 58:1413-21.
7. Pappas PG, Kauffman CA, Andes D, et al.Clinical practice guidelines for the managementof candidiasis: 2009 update by the InfectiousDiseases Society of America. Clin InfectDis 2009; 48:503-35.